2026年2月2日，康臣药业集团有限公司（01681）公布截至2026年1月31日的股份变动月报。报告期内，公司法定注册股本未发生变化，维持于50亿股，面值为每股0.1港元，总额5亿港元。
本月已发行股本由上月底的848,493,407股降至841,508,111股，减少约6,985,296股，主要原因包括公司于1月16日完成8,385,000股的股份赎回并注销，同时有1,399,704股因行使购股权而新增发行。另有100,000股在购回后尚未注销。购股权行使共为公司带来约565万港元资金。
截至2026年1月末，康臣药业已发行股份总数变更为841,508,111股。公司确认满足香港联交所的最低公众持股量要求，并遵守相关上市规则及法律法规。公告由公司秘书高海恩签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.